The results revealed that SLC35A2 might influence cancer cell metabolism through downstream molecules related to MYC, including pathways such as steroid biosynthesis, pentose phosphate pathway, and tricarboxylic acid (TCA) cycle. Here, SLC35A2 is linked to cancer.